Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04234048
Title Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors SciTech Development, LLC
Indications

mycosis fungoides

anaplastic large cell lymphoma

Sezary's disease

angioimmunoblastic T-cell lymphoma

peripheral T-cell lymphoma

cutaneous T cell lymphoma

Therapies

Fenretinide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.